By 6 years of follow-up, approximately 40% of subjects in the former group, compared with 7% in the latter, had progressed to clinical T1DM
By 6 years of follow-up, approximately 40% of subjects in the former group, compared with 7% in the latter, had progressed to clinical T1DM. of insulin monoclonal antibody. The AUY922 (Luminespib, NVP-AUY922) assay cutoff index of 0.006 was set at the 99th percentile of 100 healthy controls, and the interassay coefficient of variation AUY922 (Luminespib,…